St. Paul, MN – According to filings with the U.S. Securities and Exchange Commission, Cardio Flow is raising $5,999,997.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Kallok played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cardio Flow

Cardio Flow is an early-stage development company with a new approach to orbital atherectomy. Cardio Flow is developing the first atherectomy device for removing or modifying all types of plaque – including calcified and fibrotic plaque – in a wide range of vessel diameters. Cardio Flow’s FreedomFlow technology is the first atherectomy device to provide physicians with a comprehensive solution for removing or modifying all types of plaque in a wide range of vessel diameters. Atherectomy devices are designed to remove this plaque – the device is inserted through the patient’s artery to cut away or abrade the blockage and restore blood flow.

To learn more about Cardio Flow, visit http://cardioflow.net/

Contact:
Michael Kallok, Chief Executive Officer
651-253-1754

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved